In conclusion, our results indicate that the analysis of the expression of PDK1, PHD3, and HIF-1α by immunohistochemistry can be used to define the hypoxic status of NB tumors, which is a novel and important prognostic indicator to stratify high risk patients. Here, HIF1A is linked to neuroblastoma.